Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-26 @ 2:29 AM
Study NCT ID:
NCT00368602
Status:
TERMINATED
Last Update Posted:
2015-04-07
First Post:
2006-08-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Beta Blocker for Chronic Wound Healing
Sponsor:
University of California, Davis
Organization:
Study Overview
Official Title:
Beta Adrenergic Receptor Modulation of Burn Wound Healing
Status:
TERMINATED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lack of funding.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of treatment of chronic cutaneous ulcers and burn wounds with topical beta adrenergic antagonists (Timoptic®).
Detailed Description:
The purpose of this study is to learn more about how to heal venous leg ulcers faster and to test the safety of a drug and see what effects it has on a venous leg ulcer.
You will:
* be interviewed and examined
* have a physical exam
* have blood and urine tested
* have photographs taken of the wound
* apply medication to the leg ulcer as directed
You will:
* be interviewed and examined
* have a physical exam
* have blood and urine tested
* have photographs taken of the wound
* apply medication to the leg ulcer as directed
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: